Joint Formulary & PAD

Quetiapine - Behavioural and Psychological Symptoms of Dementia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Immediate release tablets
Associated Icons :
Guidelines
Off Label
SPC
Restrictions / Comments :
Important
Preferred

Initiation by a mental health specialist and stabilisation for at least 3 months before any request to transfer prescribing responsibility.

 

Status 2

Red
Formulations :
  • Modified release tablets
Associated Icons :
Guidelines
Off Label
SPC
Restrictions / Comments :
Important

Modified release tablets are reserved for use when immediate release tablets are not suitable.

Modified release quetiapine MAY be continued in Primary Care (after a 3-month period of stabilisation by SABP) where the use of immediate release tablets would risk destabilising the patient.

PAD Profile

ChemicalSubstance :
Quetiapine
Indication :
Behavioural and Psychological Symptoms of Dementia
Group Name :
Keywords :
Non-cognitive symptoms of dementia, BPSD, Alzheimer's Disease, aggression, antipsychotics, anticholinergic burden, aggression, dementia, Schizophrenia, Behavioural and Psychological symptoms of dementia, bipolar, Alzheimer's disease"
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
5
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Quetiapine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Behavioural and Psychological Symptoms of Dementia.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated resource pack for use by primary care prescribers for managing non-cognitive symptoms in people living with dementia.